Physician

Sreekala Vasudevan, M.D

According to 2025 Medicare claims, Sreekala Vasudevan, M.D (NPI: 1215041975) practices rheumatology in the Providence-Warwick, RI-MA market, with the plurality of this provider's patient population coming from Bristol, MA. This provider's primary affiliated billing organization is STURDY HEALTH, INC. (NPI: 1871515874; TIN: 042768252) and primary practice location at 02048-1225. Vasudevan is affiliated with the On Belay Health Solutions (ACO ID: A5260), participating under the MSSP model.

Vasudevan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 408 traditional Medicare patients, billed 6,447 HCPCS/CPT codes, and received $126,935 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 4,208 prescription claims across 464 beneficiaries totaling $3,549,614 in drug costs, led by Humira(Cf) Pen (Adalimumab). Open Payments data shows 122 records totaling $3,070. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $494,545 to $3,549,614. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	325	1,225	$59,378
2016	327	1,209	$56,411
2017	365	1,351	$68,393
2018	400	1,361	$70,072
2019	420	1,280	$69,060
2020	367	973	$48,656
2021	377	979	$63,518
2022	392	1,051	$68,552
2023	424	1,195	$74,545
2024	408	6,447	$126,935

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	264	2,307	$494,545
2016	264	2,580	$643,707
2017	305	3,116	$893,834
2018	348	3,392	$1,109,803
2019	434	3,698	$1,453,409
2020	400	3,539	$1,789,043
2021	427	3,397	$1,766,663
2022	455	3,925	$2,422,335
2023	455	4,186	$3,384,686
2024	464	4,208	$3,549,614

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	70	70	$95
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	323	602	$74
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	91	134	$56
20610	Aspiration and/or injection of fluid from large joint	61	98	$42
96372	Injection of drug or substance under skin or into muscle	37	41	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Humira(Cf) Pen	Adalimumab	126	3,528	$857,029
Rinvoq	Upadacitinib	68	2,340	$494,771
Enbrel Sureclick	Etanercept	42	1,344	$304,497
Cosentyx Sensoready Pen	Secukinumab	21	602	$292,639
Xeljanz Xr	Tofacitinib Citrate	52	1,560	$291,702

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	122	$3,070	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Sreekala Vasudevan, M.D?

Tedicare shows public-source Medicare data for Sreekala Vasudevan, M.D (NPI 1215041975), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Sreekala Vasudevan, M.D have ACO affiliation data?

Sreekala Vasudevan, M.D is shown with ACO affiliation data for On Belay Health Solutions (MSSP, ACO ID A5260).

What billing organization is linked to Sreekala Vasudevan, M.D?

Sreekala Vasudevan, M.D is linked to STURDY HEALTH, INC. (billing NPI 1871515874) in the available physician profile data.

Does Sreekala Vasudevan, M.D have Open Payments data?

Sreekala Vasudevan, M.D has 122 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.